Compelling evidence indicates that p53 acts as a transcription factor and that this activity is regulated by several factors including subcellular localization and phosphorylation status of the protein. To learn more about how these two processes determine whether p53 becomes activated, we studied the temperature sensitive murine p53, p53 val135 . At nonpermissive temperatures, p53 val135 remains sequestered in the cytoplasm of cells which express it. Electrophoretic mobility shift assays demonstrated that, under these conditions, the protein lacked DNA binding activity. However, by shifting to the permissive temperature, p53 val135 became concentrated in the nucleus, hyperphosphorylated, and had acquired the ability to bind DNA in a sequence speci®c manner. This was accompanied by the induction of two p53 regulated genes, mdm2 and p21 waf1 , which indicated that p53 val135 had become an active transcription factor. Two dimensional gel electrophoresis and tryptic peptide mapping showed that entry into the nucleus resulted in the appearance of new phosphorylated isoforms and that the protein had become extensively phosphorylation at the N-terminus. Notably, phosphorylation at the Nterminus occurred only in the nucleus, whereas phosphorylation at the C-terminus could occur in both the cytoplasm and the nucleus. Based on these observations, we suggest that phosphorylation of p53's N-terminus is compartmentally restricted.
Introduction
The tumor suppressor, p53, functions as a transcription factor that is activated in response to genotoxic agents. In cells damaged by agents such as ionizing radiation (Kastan et al., 1991; Zhan et al., 1993) , ultraviolet light (Maltzman and Czyzyk, 1984; Lu and Lane, 1993) , or chemical carcinogens (Fritsche et al., 1993) , intracellular levels of p53 became elevated and the expression of several downstream eector genes, including p21 waf1 (El-Deiry et al., 1993) and GADD45 Smith et al., 1994) , is induced. The increased production of p21 waf1 suppresses transit through the cell cycle (El-Deiry et al., 1993; Harper et al., 1993) , allowing GADD45 to facilitate the repair of damaged DNA templates (Smith et al., 1994) . Hence, p53 functions as a cell cycle checkpoint that monitors integrity of the cell's genetic material (Kuerbitz et al., 1992) . Loss of wild-type p53 function, as a consequence of mutations sustained in the p53 gene Vogelstein et al., 1989) , decreases the eciency of mutation repairs and increases the likelihood that cells with high neoplastic potential will develop due to the accumulation of genetic damages. Inactivation of p53 by genetic mutation is the most common genetic abnormality identi®ed in human cancers (Nigro et al., 1989) .
Because the biological activity of p53 is so central to the integrity of the normal cell, there is considerable interest in understanding how this activity is regulated. At least two conditions, subcellular distribution of the protein and its phosphorylation status, are important determinants of p53 functionality (Shaulsky et al., 1991; Milne et al., 1992; Fiscella et al., 1993; Mayr et al., 1995; Moll et al., 1996) . Entry of p53 into the nucleus is governed by a nuclear localization signal that is located in the C-terminal one third of the protein (Shaulsky et al., 1990b) . Site directed mutagenesis of the nuclear localization signal results in a protein that remains sequestered in the cytoplasm and does not exhibit tumor suppressor activity (Shaulsky et al., 1991) suggesting that nuclear localization is critical for tumor suppressor function. In support of this, it has been shown that a subset of tumors retain wild-type p53 genes but express a protein that remains sequestered in the cytoplasm, unable, for unknown reasons, to enter the nucleus (Moll et al., 1992) .
The phosphorylation status of p53 is determined by the activity of several kinases which target at least six dierent serines clustered in two domains on the protein (reviewed in Meek, 1994) . The N-terminus, which functions as a transactivation domain, contains four serines, 4, 6, 15, and 34 in murine p53 (Meek and Eckhart, 1988; Wang and Eckhart, 1992) , that are target substrates of a number of kinases known to be involved in regulation of cellular proliferation (Bischo et al., 1990) , signal transduction (Jamal and Zi, 1995; Milne et al., 1995) , and DNA metabolism (Lees-Miller et al., 1992) . Site directed mutagenesis of these N-terminal serines results in loss of transactivation indicating that phosphorylation of p53's Nterminus facilitates transactivation (Mayr et al., 1995) . Two other phosphorylated serines within the C-terminal domain, serines 312 and 389 in murine p53, are phosphorylated by cyclin dependent kinase 2 (CDK2) and casein kinase II (CKII) respectively (Bischo et al., 1990; Moore et al., 1992) . Phosphorylation at either of these sites causes a restructuring of the p53 protein that results in activation of DNA binding activity (Hupp et al., 1992; Wang and Prives, 1995) .
Although there is considerable knowledge relating to p53 phosphorylation, how this might be in¯uenced by subcellular localization is not known. To examine the relationship between these two processes we utilized A1-5 cells, which express the temperature sensitive murine p53 val135 protein, as an in vivo model to study activation of p53 after it enters the nucleus. We found that cytoplasmic p53 val135 was phosphorylated at serines located in the C-terminal domain but was unable to bind DNA when tested by EMSA assays. Inducing the protein to enter the nucleus caused p53 val135 to shift to the wild-type conformation, to acquire the capacity to bind DNA, and to activate p53 inducible gene expression. This was accompanied by phosphorylation in the N-terminal domain of the protein. This suggests that phosphorylation of speci®c domains on the p53 protein occur in distinct compartments within the cell.
Results

Induction of mdm2 and p21
waf1 by p53 val135¯u ctuates after shifting to 32.58C
Nuclear localization of p53 is essential for its wild-type activity (Shaulsky et al., 1991) and there is compelling evidence that this activity is a consequence of the protein's ability to stimulate gene expression (Fields and Jang, 1990; Raycroft et al., 1990) . However, it is not clear what events occur after p53 enters the nucleus which make it able to induce gene expression. Previously, we showed that shifting the incubation temperature of A1-5 cells to 32.58C (permissive temperature) resulted in nuclear localization of the temperature sensitive p53 val135 protein and this coincided with activation of its wild-type properties (Martinez et al., 1991) . Hence, we utilized these cells as a model to examine the activation of p53 val135 after it enters the nucleus. p53 val135 mediated induction of mdm2 and p21 waf1 in A1-5 cells was examined by Northern blot analysis. A1-5 cells grown at 39.58C were shifted to 32.58C and total cellular RNA isolated from samples harvested at regular intervals. The RNAs were fractionated on denaturing formaldehyde agarose gels, transferred to nylon membranes, and hybridized either with radiolabeled mdm2 or p21 waf1 cDNA probes (Figure 1 ). These experiments show that the steady state levels of both mdm2 and p21 waf1 change considerably after the shift to 32.58C and are most evident for the mdm2 message. Three hours at 32.58C results in strong induction of mdm2 message. This is immediately followed by a dramatic decrease in mdm2 RNA which is minimal at 9 hours. Thereafter, the steady state levels of mdm2 message again rise although slowly. Northern blots probed with the p21 waf1 cDNA also showed a strong induction when A1-5 cells were shifted to the permissive temperature. Although the subsequent¯uctuation in RNA levels is less dramatic than that seen for the mdm2 message, we consistently observed a modest drop in steady state levels of p21 waf1 RNA in several independent experiments. It is not immediately apparent why the depression seen at 6 hours is less for p21 waf1 . However since reduction in RNA levels is a combined eect of both expression and decay, it may be that the half-life of the p21 waf1 message is greater compared to that of the mdm2 message. We conducted similar experiments with T101-4 cells which were derived in the same way as A1-5 cells but which express the stable mutant murine p53 gene, KH215. KH215 remains sequestered in the cytoplasm even when the cells are shifted to 32.58C (Martinez et al., 1991) . In these control experiments neither mdm2 nor p21 waf1 were induced by incubating at 32.58C (data not shown). Hence, we conclude that the induction of mdm2 and p21 waf1 seen in A1-5 cells is dependent on p53 val135 and cannot be attributed to the shift in temperature.
To determine whether the apparent¯uctuations in RNA levels of mdm2 message produced a corresponding¯uctuation in the levels of the protein, we immunoprecipitated mdm2 from A1-5 cells. Figure 1 Expression of mdm2 and p21 waf1 in A1 ± 5 cells shifted to 32.58C. A1-5 cells were shifted from 39.58C to 32.58C and total RNA isolated from cells harvested 0, 3, 6, 9, 12, 24 and 48 h after the temperature shift. (a) RNA was electrophoresed on denaturing formaldehyde gels, electroblotted, and hybridized with a radiolabeled cDNA probe to either mdm2, p21 waf1 , or GAPDH. A photograph of the ethidium bromide stained gel is shown as a loading control. (b) The quantity of radioactivity hybridized to blots probed with the mdm2 (&Ð&), p21 waf1 (*---*), or the GAPDH probe (!Ð!) was quantitated using a phosphorimager and the relative values graphed and 48 h at the permissive temperature. Lysates were prepared and p53 val135 immunoprecipitated with the anti-mdm2 monoclonal antibody 2A10 (Chen et al., 1993) . The precipitates were electrophoresed on an SDS ± PAGE gel and the gels were autoradiographed (Figure 2 ). Mdm2 protein was ®rst detectable in the immunoprecipitates after 3 h of incubation at 32.58C which coincided with the ®rst detectable mdm2 message in the Northern blot analysis (Figure 1 ). The quantity of mdm2 protein was maximal at 6 h but then the quantity declined and was minimal at 9 h. The protein again accumulated slowly during the remainder of the time course. Although the kinetics were shifted slightly to later times, the apparent¯uctuations in the levels of mdm2 protein followed the¯uctuations seen in the levels of the mdm2 message. The delayed kinetics could be a cumulative eect of the time required to translate the message into protein and for the protein to be degraded. Nevertheless, these results are consistent with the notion that p53 val135 becomes an active transcription factor when it ®rst enters the nucleus and that this activity is transiently suppressed 6 h after the temperature shift.
Fluctuations in p53
val135 DNA binding activity accompany the¯uctuations in p53 mediated gene expression The¯uctuations in mdm2 and p21 waf1 message seen in A1-5 cells suggested that variations in the levels of gene expression occurred at the level of transcription. Since p53 is a transcription factor that binds DNA in a sequence speci®c manner (Kern et al., 1991) , we sought to determine whether the apparent changes in induction of gene expression by p53 val135 might be due to alterations in its DNA binding activity.
We ®rst examined nuclear extracts prepared from A1-5 cells incubated at 32.58C for 48 h for speci®c DNA binding activity by p53 val135 . Five distinct bands were observed in EMSA assays when 48 h extracts was incubated with an oligonucleotide containing the p21 waf1 p53 response element (p53re) oligonucleotide ( Figure 3a ). These same bands were not competed away by an oligonucleotide containing a scrambled p21 waf1 p53re sequence. To test for the presence of p53 val135 in these bands, extracts were depleted of p53 val135 using the anti-p53 monoclonal antibody, PAb421 ( Figure 3b ). In these depletion experiments, band 4 was eliminated and band 3 was reduced in intensity. To further test for p53 val135 in these bands, the proteins in the EMSA assays were transferred to nitrocellulose and the ®lter probed with PAb421 ( Figure 3c ). Four bands were observed with rates of migration that corresponded to four bands, bands 1, 2, 3 and 4 in Figure 3b . Based on these analyses we concluded that at least bands 3 and 4 can be attributed to two dierent sized complexes that contain p53 val135 . Although bands 1 and 2 were not eliminated by depleting the extracts with PAb421 it may be that the complexes which give rise to these bands have PAb421 epitopes that are occluded by structural changes brought about by activation or are not recognized by the antibody due to phosphorylation of serines within the region (Takenaka et al., 1995; Hecker et al., 1996) . The Western blot analysis supports this notion.
We next examined the capacity of p53 val135 to bind DNA throughout the time course. Nuclear extracts were prepared from A1-5 cells incubated at 32.58C for various times and EMSA assays conducted using aliquots that contained an equal amount of p53 val135 .
A double stranded 32 P-labeled oligonucleotide containing either the mdm2 or the p21 waf1 p53 response element (p53re) was used as the binding target ( Figure 3d and e). As can be seen no speci®c DNA binding by p53 val135 could be observed in the cytoplasmic extracts made from cells incubated at 39.58C. However, strong binding was observed 3 h after shifting the cells to 32.58C and was indicated by the appearance of band 3 in the EMSA assays. Strikingly, no DNA binding activity was observed in 6 h extracts regardless of which oligonucleotide substrate was used. However, DNA binding activity was observed in extracts made from cells incubated at 32.58C for longer periods. Interestingly, we found that the number of bands which bound the two oligonucleotides was distinctly dierent and that this pattern changed with length of incubation time at 32.58C. Western blot analysis of all of the extracts showed that the quantity of p53 val135 to be equivalent in the extracts (data not shown). Hence, the loss in activity could not be due to a loss of protein in these extracts. Therefore, p53 val135 could bind DNA at 3, 9, 12 and 48 h but not at 0 or 6 h and this corresponds to those times when mdm2 and p21 RNA levels are more abundant in the cell (Figure 1 ).
The¯uctuations in p53
val135 activity cannot be attributed to relocalization to the cytoplasm nor return to the mutant conformation Because subcellular localization of p53 val135 is subject to variation, one trivial explanation for the loss in DNA binding activity seen at 6 h could be that the protein relocalized to the cytoplasm. To test for this possibility, we examined the subcellular localization of p53 val135 in A1-5 cells after shifting from 39.58C to 32.58C using PAb421 ( Figure 4 ). As can be seen, p53 val135 was sequestered in the cytoplasm at 39.58C, with little or no p53 val135 detected in the nuclei of A1-5 cells at this temperature. However, within 3 h of shifting to 32.58C, the protein was seen to relocalize to the nucleus. We were unable to detect p53 val135 in the cytoplasm of A1-5 cells at 6 h or at any other time after shifting to the permissive temperature. Similar results were obtained using other anti-p53 antibodies. Hence, the shift to 32.58C initiated a rapid relocaliza- , 3, 6, 9, 12, 24 or 48 h after the temperature shift. MDM2 was immunoprecipitated using 2A10 antibody. Immunoprecipitates were electrophoresed on SDS ± PAGE gels, dried, and autoradiographed tion of p53 val135 to the nucleus that was complete by 3 h and this compartmentalization was stably maintained throughout the remainder of the time course. Therefore, the loss of p53 val135 DNA binding activity seen at 6 h could not be explained by exit of the protein from the nucleus. val135 DNA binding activity after shifting to 32.58C. (a) Nuclear extracts prepared from A1-5 cells incubated at 32.58C for 48 h were incubated in three separate reactions with a radiolabeled olignonucleotide containing the p21 p53 response element. To test for speci®city of binding, either no unlabeled DNA (no competitor), 1 mg of unlabeled p21 waf1 p53 response element oligonucleotide (cold p21), or 1 mg of oligonucleotide containing a scrambled p21 waf1 p53 response element (cold S-p21) was added to the reaction and the reactions electrophoresed on 16TBE gels at 48C. Autoradiographs are depicted with the four bands which appear consistently in these assays numbered at the left. The asterisk denotes a nonspeci®c DNA binding protein.
(b) To test for the presence of p53 val135 in the four bands, 48 h A1-5 nuclear extracts were either not treated (untreated), incubated with protein A sepharose beads (pro.A), or with protein A sepharose beads saturated with PAb421 (421) . The extracts were then tested for DNA binding as in (a) using a radiolabeled oligonucleotide containing the p21 waf1 p53 response element. (c) Identity of bands in the EMSA assays was further tested by Western blotting. Proteins in an EMSA assay, conducted as above, were electrophoretically transferred to nitrocellulose and then the proteins denatured. The ®lter was then probed with PAb421. DNA binding activity of p53 val135 was tested in nuclear extracts prepared from A1-5 cells shifted from 39.58C to 32.58C and incubated for 3, 6, 9, 12 and 48 h. For time zero, a cytoplasmic (S-100) extract was prepared from A1-5 cells incubated at 39.58C. Aliquots of each of the time point extracts containing equivalent quantitities of p53 val135 were incubated with an 32 P-labeled oligonucleotide containing either the mdm2 p53 response element (d), or the p21 waf1 p53 response element (e) for 1 h at 158C. Subsequently, binding reactions were electrophoresed at 48C on nondenaturing 16TBE PAGE gels, and the gels dried and autoradiographed. Resultant bands are marked to the right of each panel Because the p53 val135 protein is¯exible and able to undergo a shift in conformation, we also tested the possibility that p53 val135 had reverted back to the mutant conformation at 6 h. To test for this, we probed the conformation of p53 val135 using conformation speci®c monoclonal antibodies, immunoprecipitating the protein from 35 S-methionine labeled cell extracts ( Figure 5 ). As expected, mutant p53 val135 constituted the majority (64%) of the protein at 39.58C. However, 3 h after shifting to the 32.58C 75% of the p53 val135 was found to have the wild-type conformation while only 25% of the protein had the mutant conformation. This ratio remained constant throughout the remainder of the time course. Thus the shift to permissive temperature produced a stable nuclear localization of p53 val135 with the wild-type conformation. The loss of DNA binding activity at 6 h, therefore, could not be explained by a reversion to the mutant conformation.
Activation of p53
val135 for DNA binding coincides with hyperphosphorylation
Our experiments indicated that p53 val135 became active as a transcription factor after entering the nucleus. However, the mechanism by which this occurred was not immediately apparent. Others have shown that reversible phosphorylation acts to regulate the p53's biological activity. Hence, we speculated that changes in phosphorylation accompanied nuclear translocation. and determining its speci®c activity ( Figure 6 ). Three hours after shifting to 32.58C caused a modest increase in the protein's speci®c activity which was followed by a decrease of nearly 50% at 6 h. Subsequently the speci®c activity of the protein increased. Notably, the presence of hypophosphorylated protein coincides with loss of DNA binding activity.
The correlation between altered phosphorylation states and DNA binding activity and transactivation suggested that hyperphosphorylation was important for activating p53 . This hyperphosphorylation could come about either by uniform phosphorylation and dephosphorylation of the protein at all phosphorylatable serines or could be due to a shift in the abundance of some isoforms and not others. Others have shown that phosphorylated p53 exists in multiple isoforms that can be distinguished by two dimensional (2D) gel electrophoresis (Selkirk et al., 1994 extracts and electrophoresed on 2D gels revealed at least six distinct isoforms (Figure 7) , with apparent isoelectric points which ranged between pH 6.3 and 7.3. This range of isoelectric points is consistent with previously published observations (Selkirk et al., 1994) . Labeling with [ 35 S]methionine shows that the majority of protein exists in two isoforms and that these remain predominant throughout the time course. By contrast, analysis of 32 P-orthophosphate labeled proteins reveals that the shift to 32.58C results in several distinct protein isoforms that were not observed in cells incubated at 39.58C. Comparison of the isoforms obtained from cells incubated for 6 h at 32.58C shows a uniform reduction in all isoforms rather than a decrease in any one isoform (note that the 6 h sample was overexposed). All isoforms observed at 3 h were also seen at 6 h but with reduced intensities and are similar to that seen in cells incubated at 32.58C for 48 h. Hence, the reduced DNA binding activity observed at 6 h was due to an overall reduction in phosphorylation and did not result from elimination of any one speci®c isoform.
Analysis of phosphorylated p53 by tryptic peptide mapping shows that the phosphorylation status of several serines located in two clusters in the N-terminal and C-terminal domains are important for activity. val135 protein was immunoprecipitated with PAb421 and the immunoprecipitates electrophoresed on two dimensional gels using isoelectric focusing in the ®rst dimension and SDS ± PAGE in the second dimension. It should be noted that the 6 h sample in (b) was exposed four times longer so that all isoforms which were present could be clearly observed This together with our observation that new isoforms appeared in A1-5 cells when the incubation temperature was shifted to 32.58C prompted us to examine phosphorylated residues by tryptic peptide mapping. A1-5 cells were incubated either at 39.58C or 32.58C for 3 h, radiolabeled with [ 32 P]orthophosphate, and p53 val135 puri®ed by immunoprecipitation. Tryptic peptides were prepared as described in Materials and methods and separated by electrophoresis in the ®rst dimension and chromatography in the second dimension (Figure 8 ). The pattern of phosphorylated peptides was dramatically altered by incubating at 32.58C. At 39.58C two phosphopeptides which have the same mobilities as the two C-terminal peptides which contain serines 312 and 389 were prominent. These two phosphopeptides were also readily visible in the 32.58C protein. In addition, several more hydrophilic phosphopeptides which exhibit mobilities similar to those calculated for p53 N-terminal peptides generated by trypsin digestion became visible. Phosphopeptide X could not be de®nitively identi®ed. From these experiments we conclude that p53 val135 became phosphorylated at the N-terminus upon entering the nucleus.
Discussion
A1-5 cells provide a convenient model for examining the regulation of p53 activity because p53 val135 remains sequestered in the cytoplasm until these cells are shifted to the permissive temperature. Hence, normal cell growth can occur in spite of the presence of large quantities of p53 which normally would adversely aect cell growth. Shifting these cells to the permissive temperature then precipitates events which result in activation of p53 val135 with all the properties of the wildtype protein (Michalovitz et al., 1990; Martinez et al., 1991) . This provides a convenient model system with which to examine the relationship between the biological activity of the protein and the biochemical events that regulate this activity. Here we have utilized this model system to show that regulation of p53-mediated transactivation involves governing of the subcellular distribution of the protein as well as its phosphorylation within speci®c domains.
At 39.58C p53 val135 was sequestered in the cytoplasm and could not bind DNA as demonstrated by electrophoretic mobility shift assays. Interestingly, tryptic peptide mapping showed that the protein was phosphorylated at the C-terminus which has been shown to activate p53's DNA binding function (Hupp et al., 1992) . This is consistent with what is known about the subcellular localization of cdc2 and CKII, two kinases that target the C-terminal domain of the p53 protein for phosphorylation. Both enzymes can be found in the cytoplasm and the compartmentalization appears to be regulated in a cell cycle dependent manner (Heald et al., 1993; Pepperkok et al., 1994) as is p53 (Shaulsky et al., 1990a) . This suggests that wildtype p53 may be fully capable of binding DNA even while still in the cytoplasm. However in the case of p53 val135 , cytoplasmic protein also has a mutant conformation. Hence, it is not surprising that cytoplasmic p53 val135 lacks DNA binding activity. Shifting A1-5 cell incubation temperature to 32.58C caused p53 val135 to translocate to the nucleus which precipitated a number of changes which resulted in activation of the protein's wild-type functions. A majority of the protein could be immunoprecipitated with a wild-type speci®c monoclonal antibody, EMSA assays showed that p53 val135 acquired DNA binding activity and tryptic peptide mapping showed that the N-terminal domain of the protein was phosphorylated. All of these modi®cations coincided with a strong induction of the two p53 inducible genes, mdm2 and p21 waf1 . This is consistent with what others have found regarding regulation of p53 val135 phosphorylation with respect to temperature (Knippschild et al., 1995) . It is of some interest to note that nuclear but not cytoplasmic p53 val135 was phosphorylated in the Nterminal domain. This suggests that the phosphorylation of speci®c domains on the p53 protein also occurs in a compartment speci®c fashion.
Interestingly, p53 val135 functionality did not remain stable but instead¯uctuated showing a transient decline so that activity was at a mininum 6 h after shifting the cells to permissive temperature. This was re¯ected both in a loss of DNA binding activity and in reduction of p53-inducible gene expression. This might be expected considering that initial activation of p53 val135 resulted in mdm2 expression which functions as a negative regulator of p53 by inhibiting its transactivation function (Wu et al., 1993) . Indeed the levels of MDM2 protein are highest at 6 h ( Figure 2) . However, it is unlikely that the lull in p53 val135 activity seen at this time is due simply to an interaction with MDM2 because there is also a reduction in the overall phosphorylation of p53 val135 . Shifting to 32.58C resulted in the appearance of several novel phosphorylated p53 val135 isoforms all of which were much reduced at 6 h. Given the aforementioned importance of phosphorylation in activation of p53 it seems likely that the reduction in phosphorylation also contributed to loss of activity. It is not clear whether MDM2 played a direct role in this. To our knowledge MDM2 has not been reported to have phosphatase activity. However, because MDM2 appears to be a transcription factor it is conceivable that it could activate the expression of a phosphatase which targets p53.
An additional novel observation in these experiments was that the two dierent p53 response elements which were used in the EMSA assays appeared to bind distinct sets of p53 val135 containing complexes. Moreover, the number of complexes that bound to each response element increased with increasing time of incubation at 32.58C. The p21 waf1 p53 response element bound the most complexes, some of which appeared only after 48 h of incubation at 32.58C. The oligonucleotide containing the mdm2 p53 response element only bound two complexes, but both of these exhibited the same rate of migration as two of the complexes which bound the p21 waf1 p53re oligonucleotide. Hence, it appears that the complex which bound the mdm2 p53re oligonucleotide had a wider range of speci®city. Moreover, this suggests that complexes which produce bands 1, 2 and 4 (see Figure 3d and e) can discriminate between the two p53 response elements. It is not likely that the number of complexes bound to these oligonucleotides is a function of length, since the mdm2 p53re probe, which binds the least number of complexes is the longer of the two, 60 nucleotides compared to 34 nucleotides for the p21 waf1 p53re probe. This suggests the interesting possibility that p53 complexes of dierent sizes may have slightly dierent binding speci®cities. Aside from having shown that they contain p53 val135 , the composition of these complexes is yet to be determined.
Materials and methods
Cells and procedures using antibodies
A1-5 cells were derived by transformation of primary rat embryo ®broblasts with an activated ras and p53 val135 and the conditions used to propagate them have been described in detail previously (Martinez et al., 1991) . Three monoclonal antibodies to p53, PAb421, PAb246 and PAb240, were used in these studies. PAb421 is panspeci®c and detects all p53 proteins regardless of conformation (Gannon et al., 1990) . PAb246 recognizes only wild-type murine p53 (Yewdell et al., 1986) and PAb240 recognizes mutant human and mutant murine p53 proteins (Gannon et al., 1990) . RA3-2C2 is speci®c for murine p53 (Rotter et al., 1980) .
To detect subcellular localization of p53 val135
, coverslips with sample cells were rinsed with cold PBS (3 mM KCl, 1 mM KH 2 PO 4 , 0.2 mM MgCl 2 , 137 mM NaCl, 8 mM Na 2 HPO 4 ) and ®xed in ice cold methanol/acetone (50 : 50) for 2 min. To stain for p53 val135 , cells on coverslips were rehydrated for 2 min in TE (10 mM Tris-Cl, pH 7.5, 1 mM EDTA) and then incubated successively with hybridoma supernatant containing PAb421 and FITC-conjugated antimouse IgG (Gibco/BRL), each for 1 h. Between each antibody the coverslips were washed three times with PBS to reduce background. To determine the fraction of cells with , and pelleted by centrifugation at 48C. Cells were lysed in 500 ml lysis buer (50 mM Tris (pH 8.0), 50 mM EDTA, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl¯uoride, 50 mM sodium¯uoride, 1 mM sodium orthovanadate), cleared of cell debris by centrifugation at 14 000 g for 10 min, and the protein concentration determined using the Bradford assay (BioRad). Equal quantities of protein were combined with the appropriate monoclonal antibody, 35 ml protein A sepharose beads (beads/lysis buer, 50 : 50), and lysis buer in a ®nal volume of 500 ml and the reactions rotated overnight at 48C. Beads containing the immunocomplexes were collected by centrifugation and washed three times with SNNTE (5% sucrose, 1% Nonidet P-40, 0.5 M NaCl, 50 mM Tris (pH 7.4), 5 mM EDTA) and once with RIPA buer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 1% (wt/vol) sodium deoxycholate (SDS). The immunopuri®ed proteins were solubilized in SDS ± PAGE sample buer (125 mM Tris (pH 6.8), 4% SDS, 10% glycerol, 0.005% bromphenol blue, 10% 2-mercaptoethanol) and electrophoresed on 10% SDS ± PAGE gels.
To detect p53 val135 by immunoblotting, samples were electrophoresed on 10% SDS ± PAGE gels and electroblotted onto nitrocellulose ®lters. Nonspeci®c binding activity of the ®lter was blocked using 3% BSA in 150 mM NaCl, 50 mM Tris-Cl (pH 7.4). The ®lter was then incubated successively with PAb421, biotinylated antimouse IgG (Sigma), and peroxidase labeled avidin (Sigma) in 16NETG (150 mM NaCl, 5 mM EDTA, 50 mM Tris-Cl (pH 7.4), 0.25% gelatin, 0.05% NP-40). Between each step, the ®lter was washed 56 in 16NETG supplemented with 0.1% SDS and 0.5% Triton X-100. A ®nal brief rinse in distilled water preceded detection of bands by ECL (Amersham).
Two dimensional gel electrophoresis Two dimensional gel electrophoresis was conducted essentially as described by Selkirk et al. (1994) . p53 val135 protein, radiolabeled either with [
35 S]methionine or [ 32 P]orthophosphate was immunoprecipitated with PAb421 as described above. Washed beads were given a ®nal rinse in TE (10 mM Tris-Cl, pH 7.5, 1 mM EDTA) and then the immunoprecipitates solubilized in 45 ml of IEF buer (9 M urea, 4% NP-40, 2% LKB (pH 3 ± 9) ampholines, 100 mM dithiothreitol). Beads were removed by centrifuging brie¯y and the supernatants applied to 13 cm61.5 mm tube gels (9.17 M urea, 2% Pharmacia (pH 3 ± 10) ampholines, 4% acrylamide, 2% NP-40). Electrophoresis was for 15 h at 450 volts and 1 h at 1000 volts. The anode buer was 10 mM phosphoric acid and the cathode buer was 30 mM NaOH. Subsequently gels were extruded from the tubes, soaked for 1 h in SDS ± PAGE sample buer, loaded onto 10% SDS ± PAGE gels, and electrophoresed at 40 mA per gel until the dye front reached the bottom of the gel. Gels were ®xed, dried, and then autoradiographed.
Tryptic peptide mapping
32 P-labeled p53 val135 was puri®ed from cell extracts by immunoprecipitation with PAb421 and the immunoprecipitates electrophoresed on SDS ± PAGE gels. Fractionated proteins were electrophoretically transferred to nitrocellulose, digested with trypsin, and the resultant peptidex oxidized as described (Luo et al., 1991) . After enzymatic digestion, peptides were separated on cellulose thin-layer plates by electrophoresis at pH 1.9 for 35 min at 1 kV in the ®rst dimension and by chromatography in the second dimension (Boyle et al., 1991) .
Mobility shift assays Twenty 10 cm plates of A1-5 cells were grown to 95% con¯uency at 39.58C, shifted to 32.58C, and harvested 3, 6, 9, 12 or 48 h later. Cells were scraped from the plates and nuclear extracts prepared as described by Dignam et al. (1983) . For time zero, when p53 val135 is sequestered in the cytoplasm, S100 extracts were prepared to obtain cytoplasmic proteins. The dialyzed extracts were aliquoted,¯ash frozen, and stored in liquid nitrogen until needed. Protein concentration of the extracts, determined using the BioRad protein assay, was typically about 5 micrograms per microliter.
Oligonucleotides used in this study were; mdm2 p53 response element containing, 5'-GGTCAAGTTGGGAC-ACGTCCGGCGT CGGC TGT CGGAGGAGCAAGTCCT-GACATGTCTCC-3'; 5'-GGAGACATGTCAGGACTTAG-CTCCTCCGAC AGCCGACGCCGGACGTGTCCAACT-3' p21 waf1 p53 response element containing, 5'-TCGA GTT-TAATGG ACTTTAATGGCC TTTAATTTT-3'; 5'-GAA-AATTAAAGGCCATTAAAGTCCATTAAAC-3' containing the scrambled p21 waf1 p53 response element, 5'-TATGCCAATGTGTACCGAACGG-3'; 5'-GTTCGGTA-CACATTGGCATAGG-3'. Single stranded oligonucleotides were annealed and labeled with [a- 32 P]dATP using Klenow polymerase.
To test extracts for DNA binding activity, 10 nanograms of 32 P-labeled oligonucleotide, 1 mg acetylated bovine serum albumin (Gibco), 2 mg poly d(I-C) (Boehringer Mannheim) and 25 mg of proteins from nuclear extracts were combined in a 20 ml reaction mixture that contained 72 mM KCl, 13% glycerol, 10.6 mM HEPES (pH 7.9), 0.1 mM EDTA and 0.8 mM MgCl 2 . Reactions were incubated at 158C for 1 h and then applied to 16tris-borate, 5% polyacrylamide gel containing 2.5% glycerol. Gels were equilibrated at 48C and pre-electrophoresed at 200 V for at least 1 h before applying samples. Electrophoresis continued for 2.5 h, at 200 V, 48C. The gels were dried and autoradiographed on Kodak XAR ®lm.
Northern blot analysis
Total RNA was extracted from cell samples using Trizol Reagent (Gibco/BRL) according to manufacturer's recommendations. Ten micrograms of each RNA sample was electrophoresed on formaldehyde agarose gels and transferred to nylon membranes. Blots were prehybridized and hybridized at 688C in Church buer (250 mM Na 2 HPO 4 , 7% SDS, 1% BSA) with probes labeled with [a-32 P]dATP by nick translation. Hybridized blots were washed as described in Maniatis et al. (1982) and autoradiographed.
